Daratumumab (anti-CD38)

製品コード：A2027         Batch: A202702

印刷

Daratumumab (anti-CD38) is a recombinant monoclonal antibody to CD38. Daratumumab is an investigational anti-cancer drug which is indicated for the treatment of adult patients with multiple myeloma. MW =145.4 kDa.

製品説明

CAS No. 945721-28-8
Formulation PBS Buffer, PH 7.4
Isotype Human IgG1
Source Human
Storage
(From the date of receipt)		 Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Shipping Shipped under low temperature conditions
Purity 99%
Protein concentration 5.72 mg/ml
Endotoxin Level ＜1EU/mg

Selleckの高級品が、幾つかの出版された研究調査結果（以下を含む）で使われた：

Developing high-affinity decoy receptors to treat multiple myeloma and diffuse large B cell lymphoma [ J Exp Med, 2022, 219(9)e20220214] PubMed: 35881112

人間や獣医の診断であるか治療的な使用のためにでない。